Frontier Investment Mgmt Co. lessened its position in shares of Monsanto Company (NYSE:MON) by 6.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,251 shares of the basic materials company’s stock after selling 1,559 shares during the quarter. Frontier Investment Mgmt Co.’s holdings in Monsanto were worth $2,634,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. Intl Fcstone Inc. purchased a new stake in Monsanto during the 2nd quarter valued at about $794,000. Paradigm Financial Advisors LLC grew its stake in Monsanto by 44.7% during the 2nd quarter. Paradigm Financial Advisors LLC now owns 17,316 shares of the basic materials company’s stock valued at $2,050,000 after purchasing an additional 5,351 shares during the last quarter. Ashburton Jersey Ltd grew its stake in Monsanto by 20.4% during the 2nd quarter. Ashburton Jersey Ltd now owns 21,642 shares of the basic materials company’s stock valued at $2,562,000 after purchasing an additional 3,660 shares during the last quarter. WFG Advisors LP grew its stake in Monsanto by 30.9% during the 2nd quarter. WFG Advisors LP now owns 3,112 shares of the basic materials company’s stock valued at $368,000 after purchasing an additional 735 shares during the last quarter. Finally, Toronto Dominion Bank grew its stake in Monsanto by 23.3% during the 2nd quarter. Toronto Dominion Bank now owns 954,563 shares of the basic materials company’s stock valued at $112,960,000 after purchasing an additional 180,243 shares during the last quarter. Institutional investors and hedge funds own 74.77% of the company’s stock.
Several research firms have weighed in on MON. Barclays PLC reiterated an “equal weight” rating and set a $124.00 price target (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. BMO Capital Markets reiterated a “buy” rating and set a $128.00 price target on shares of Monsanto in a research note on Thursday, October 5th. Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Wells Fargo & Company boosted their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research note on Tuesday, October 10th. Finally, BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a research note on Thursday, June 29th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Monsanto has an average rating of “Hold” and a consensus target price of $124.61.
Monsanto Company (NYSE:MON) traded up 0.10% during trading on Friday, reaching $122.15. The company had a trading volume of 1,552,031 shares. The firm has a 50-day moving average of $119.50 and a 200-day moving average of $117.58. Monsanto Company has a 1-year low of $97.35 and a 1-year high of $122.80. The stock has a market capitalization of $53.68 billion, a price-to-earnings ratio of 24.00 and a beta of 1.07.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The firm had revenue of $2.69 billion for the quarter, compared to analyst estimates of $2.51 billion. During the same quarter last year, the company posted $0.07 earnings per share. The business’s revenue was up 4.8% on a year-over-year basis. On average, analysts anticipate that Monsanto Company will post $5.70 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date is Thursday, October 5th. Monsanto’s dividend payout ratio is presently 42.27%.
ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://transcriptdaily.com/2017/10/21/monsanto-company-mon-shares-sold-by-frontier-investment-mgmt-co.html.
In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of Monsanto stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $122.25, for a total value of $964,552.50. Following the completion of the sale, the vice president now directly owns 38,600 shares in the company, valued at approximately $4,718,850. The disclosure for this sale can be found here. Insiders sold a total of 44,916 shares of company stock worth $5,404,894 in the last ninety days. 0.79% of the stock is owned by corporate insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.